Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Tóth, Kinga ^a   Sipos, Ferenc ^a   Kalmár, Alexandra ^a   Patai, Árpád V ^a   Wichmann, Barnabás ^b   Stoehr, Robert ^c   Golcher, Henriette ^c   Schellerer, Vera ^c   Tulassay, Zsolt ^a,b   Molnár, Béla ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; SEPTIN 9; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER LOCALIZATION; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA ISOLATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUALITATIVE ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GUAIAC; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEPTINS;

EID: 84866661786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046000     Document Type: Article

References (40)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Lieberman DA, (2009) Clinical practice. Screening for Colorectal Cancer. N Engl J Med 361: 1179-1187.
3. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E, (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 1: CD001216.
4. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134: 1570-1595.
5. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, et al. (2008) Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 359: 1207-1217.
6. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, et al. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375: 1624-1633.
7. Müller AD, Sonnenberg A, (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123: 904-910.
8. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN, (2006) Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 295: 2366-2373.
9. Wild N, Andres H, Rollinger W, Krause F, Dilba P, et al. (2010) A combination of serum markers for the early detection of colorectal cancer. Clin Cancer Res 16: 6111-6121.
10. Chen JS, Chen KT, Fan WC, Yu JS, Chang YS, et al. (2010) Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer. Clin Chem Lab Med 48: 719-725.
11. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, et al. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327.
12. Tan EM, Schur PH, Carr RI, Kunkel HG, (1966) Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45: 1732-1740.
13. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ, (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650.
14. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, et al. (2008) DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54: 414-423.
15. Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, et al. (2008) Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 3: e3759.
16. deVos T, Tetzner R, Model F, Weiss G, Schuster M, et al. (2009) Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55: 1337-1346.
17. Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, et al. (2010) Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 5: e9061.
18. Payne SR, (2010) From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood. Epigenomics. 2: 575-585.
19. Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, et al. (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 9: 133.
20. Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, et al. (2008) Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 23: 418-423.
21. Lieberman D, (2009) Colon cancer screening and surveillance controversies. Curr Opin Gastroenterol 25: 422-427.
22. Thirunavukarasu P, Sukumar S, Sathaiah M, Mahan M, Pragatheeshwar KD, et al. (2011) C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. J Natl Cancer Inst 103: 689-697.
23. Goldstein MJ, Mitchell EP, (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23: 338-351.
24. Hara M, Sato M, Takahashi H, Takayama S, Takeyama H, (2010) Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III. J Surg Oncol 102: 154-157.
25. Hall PA, Russell SE, (2004) The pathobiology of the septin gene family. J Pathol 204: 489-505.
26. www.epigenomics.com.
27. Ghazi S, Lindforss U, Lindberg G, Berg E, Lindblom A, et al. (2012) Analysis of colorectal cancer morphology in relation to sex, age, location, and family history. J Gastroenterol DOI: 10.1007/s00535-011-0520-9.
28. Benedix F, Schmidt U, Mroczkowski P, Gastinger I, Lippert H, et al. (2011) Colon carcinoma-classification into right and left sided cancer or according to colonic subsite?-Analysis of 29,568 patients. Eur J Surg Oncol 37: 134-139.
29. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, et al. (2001) Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 195: 171-178.
30. Komuro K, Tada M, Tamoto E, Kawakami A, Matsunaga A, et al. (2005) Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 124: 216-224.
31. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N, (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15: 2388-2394.
32. Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, et al. (2011) Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare data. J Clin Oncol 29: 4401-4409.
33. Bauer KM, Hummon AB, Buechler S, (2011) Right-side and left-side colon cancer follow different pathways to relapse. Mol Carcinog DOI: 10.1002/mc.20804.
34. Birkenkamp-Demtroder K, Olesen SH, Sørensen FB, Laurberg S, Laiho P, et al. (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54: 374-384.
35. Tanaka J, Watanabe T, Kanazawa T, Tada T, Kazama Y, et al. (2007) Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones. J Surg Oncol 96: 611-618.
36. Patai AV, Molnár B, Kalmár A, Schöller A, Tóth K, et al. (2012) Role of DNA methylation in colorectal carcinogenesis. Dig Dis 30: 310-315 DOI: 10.1159/000337004.
37. Sugai T, Habano W, Jiao YF, Tsukahara M, Takeda Y, et al. (2006) Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 8: 193-201.
38. Steele RJ, McClements P, Watling C, Libby G, Weller D, et al. (2011) Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut DOI:10.1136/gutjnl-2011-300535.
39. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, et al. (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150: 1-8.
40. Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H, (2011) Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer 104: 1779-1785.